Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
See All Experts
featured
Published in Cardiology and
1 other channel

Journal Scan / Research · November 10, 2022

Effect of Sacubitril/Valsartan vs Ramipril on Cardiovascular Events in Patients With Acute Myocardial Infarction

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Giselle Suero-Abreu MD, PhD, MSc

Clyde Yancy MD, MSc, MACC, FAHA, MACP, FHFSA

Circulation
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Circulation 2022 Nov 02;[EPub Ahead of Print], R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett, EF Lewis, C Granger, L Køber, A Maggioni, DL Mann, JJV McMurray, JL Rouleau, SD Solomon, G Ducrocq, O Berwanger, CG De Pasquale, U Landmesser, M Petrie, DSK Leng, P van der Meer, M Lefkowitz, Y Zhou, E Braunwald

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated